These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 27491320)

  • 21. The association between gene polymorphisms and risk of nasopharyngeal carcinoma.
    Yang J; Li L; Yin X; Wu F; Shen J; Peng Y; Liu Y; Sun Y; Lu H; Zhang Y
    Med Oncol; 2015 Jan; 32(1):398. PubMed ID: 25481674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CYP2E1 RsaI/PstI polymorphism and liver cancer risk among east Asians: a HuGE review and meta-analysis.
    Tian Z; Li YL; Zhao L; Zhang CL
    Asian Pac J Cancer Prev; 2012; 13(10):4915-21. PubMed ID: 23244081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan.
    Hildesheim A; Anderson LM; Chen CJ; Cheng YJ; Brinton LA; Daly AK; Reed CD; Chen IH; Caporaso NE; Hsu MM; Chen JY; Idle JR; Hoover RN; Yang CS; Chhabra SK
    J Natl Cancer Inst; 1997 Aug; 89(16):1207-12. PubMed ID: 9274915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meta-analyses of the effect of cytochrome P450 2E1 gene polymorphism on the risk of head and neck cancer.
    Lu D; Yu X; Du Y
    Mol Biol Rep; 2011 Apr; 38(4):2409-16. PubMed ID: 21076874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymorphisms of the CYP1A1 and CYP2E1 genes in head and neck squamous cell carcinoma risk.
    Cury NM; Russo A; Galbiatti AL; Ruiz MT; Raposo LS; Maniglia JV; Pavarino EC; Goloni-Bertollo EM
    Mol Biol Rep; 2012 Feb; 39(2):1055-63. PubMed ID: 21590276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The association between CYP2E1 polymorphisms and hepatotoxicity due to anti-tuberculosis drugs: a meta-analysis.
    Sheng YJ; Wu G; He HY; Chen W; Zou YS; Li Q; Zhong L; Huang YM; Deng CL
    Infect Genet Evol; 2014 Jun; 24():34-40. PubMed ID: 24607341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Genetic polymorphism of cytochrome P450 2E1 and the risk of nasopharyngeal carcinoma].
    Ben Chaaben A; Abaza H; Douik H; Chaouch L; Ayari F; Ouni N; Mamoghli T; Ben Guezella D; Mejri R; Harzallah L; Guemira F
    Bull Cancer; 2015 Dec; 102(12):967-72. PubMed ID: 26582733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CYP2E1PstI/RsaI polymorphism and interaction with tobacco, alcohol and GSTs in gastric cancer susceptibility: A meta-analysis of the literature.
    Boccia S; De Lauretis A; Gianfagna F; van Duijn CM; Ricciardi G
    Carcinogenesis; 2007 Jan; 28(1):101-6. PubMed ID: 16837478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CYP2E1 PstI/RsaI polymorphism and interaction with alcohol consumption in hepatocellular carcinoma susceptibility: evidence from 1,661 cases and 2,317 controls.
    Liu C; Wang H; Pan C; Shen J; Liang Y
    Tumour Biol; 2012 Aug; 33(4):979-84. PubMed ID: 22249978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of cytochrome P450 2E1 genetic polymorphisms in relation to human lung cancer.
    Kato S; Shields PG; Caporaso NE; Sugimura H; Trivers GE; Tucker MA; Trump BF; Weston A; Harris CC
    Cancer Epidemiol Biomarkers Prev; 1994 Sep; 3(6):515-8. PubMed ID: 8000304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of combined CYP2E1 gene polymorphism with the risk for esophageal squamous cell carcinoma in Huai'an population, China.
    Liu R; Yin LH; Pu YP
    Chin Med J (Engl); 2007 Oct; 120(20):1797-802. PubMed ID: 18028774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytochrome P450 2E1 DraI polymorphisms in lung cancer in minority populations.
    Wu X; Amos CI; Kemp BL; Shi H; Jiang H; Wan Y; Spitz MR
    Cancer Epidemiol Biomarkers Prev; 1998 Jan; 7(1):13-8. PubMed ID: 9456237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The polymorphism of CYP2E1 Rsa I/Pst I gene and susceptibility to respiratory system cancer: a systematic review and meta-analysis of 34 studies.
    Xu L; Yang M; Zhao T; Jin H; Xu Z; Li M; Chen H
    Medicine (Baltimore); 2014 Dec; 93(27):e178. PubMed ID: 25501063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytochrome P4502E1 genetic polymorphisms and risk of nasopharyngeal carcinoma: results from a case-control study conducted in Taiwan.
    Hildesheim A; Chen CJ; Caporaso NE; Cheng YJ; Hoover RN; Hsu MM; Levine PH; Chen IH; Chen JY; Yang CS
    Cancer Epidemiol Biomarkers Prev; 1995 Sep; 4(6):607-10. PubMed ID: 8547826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytochrome P450 2E1 RsaI/PstI polymorphism and risk of esophageal cancer: A meta-analysis of 17 case-control studies.
    Leng WD; Zeng XT; Chen YJ; Duan XL; Niu YM; Long RP; Luo ZX
    Exp Ther Med; 2012 Nov; 4(5):938-948. PubMed ID: 23226753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A case-control and a family-based association study revealing an association between CYP2E1 polymorphisms and nasopharyngeal carcinoma risk in Cantonese.
    Jia WH; Pan QH; Qin HD; Xu YF; Shen GP; Chen L; Chen LZ; Feng QS; Hong MH; Zeng YX; Shugart YY
    Carcinogenesis; 2009 Dec; 30(12):2031-6. PubMed ID: 19805575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between CYP2E1 polymorphisms and risk of gastric cancer: An updated meta-analysis of 32 case-control studies.
    Zhang MX; Liu K; Wang FG; Wen XW; Song XL
    Mol Clin Oncol; 2016 Jun; 4(6):1031-1038. PubMed ID: 27284439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of genetic polymorphisms of
    Yang S; Hwang SJ; Park JY; Chung EK; Lee JI
    BMJ Open; 2019 Aug; 9(8):e027940. PubMed ID: 31375612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclin D1 G870A polymorphism and risk of nasopharyngeal carcinoma: a case-control study and meta-analysis.
    Liao D; Wu Y; Pu X; Chen H; Luo S; Li B; Ding C; Huang GL; He Z
    PLoS One; 2014; 9(11):e113299. PubMed ID: 25409185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytochrome P450 2E1 RsaI/PstI polymorphism is associated with urologic cancer risk: evidence from a meta-analysis.
    Lin YC; Wu X; Zhou XQ; Ren R; Su ZX; Liu CX
    Int J Clin Exp Med; 2015; 8(6):8927-37. PubMed ID: 26309545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.